Cannara Biotech Inc. (TSXV:LOVE)

Canada flag Canada · Delayed Price · Currency is CAD
1.200
0.00 (0.00%)
Jun 6, 2025, 3:54 PM EDT
62.16%
Market Cap 109.72M
Revenue (ttm) 94.07M
Net Income (ttm) 13.40M
Shares Out 91.43M
EPS (ttm) 0.14
PE Ratio 8.64
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,365
Average Volume 27,070
Open 1.220
Previous Close 1.200
Day's Range 1.200 - 1.220
52-Week Range 0.520 - 1.460
Beta 0.23
RSI 39.41
Earnings Date Jul 18, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]

Sector Healthcare
Founded 2017
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol LOVE
Full Company Profile

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.

Financial Statements

News

There is no news available yet.